Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.

Relaño-Rodríguez, Ignacio; Juárez-Sánchez, Raquel; Pavicic, Carolina; Muñoz, Eduardo; Muñoz-Fernández, Maria Ángeles

Relaño-Rodríguez, Ignacio; Juárez-Sánchez, Raquel; Pavicic, Carolina; Muñoz, Eduardo; Muñoz-Fernández, Maria Ángeles.

Affiliation

Relaño-Rodríguez I; Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Juárez-Sánchez R; Health Research Institute Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, Madrid, Spain.
Pavicic C; Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
Muñoz E; Innohealth, Parque Científico de Madrid, Madrid, Spain.
Muñoz-Fernández MÁ; Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

J Nanobiotechnology ; 17(1): 69, 2019 May 21.

Article in En | MEDLINE | ID: mdl-31113488

Subject(s)

Adjuvants, Immunologic/pharmacology; Anti-HIV Agents/pharmacology; Dendrimers/chemistry; HIV Infections/drug therapy; Polymers/chemistry; Silanes/chemistry; Bryostatins/pharmacology; Cell Line; Cell Survival/drug effects; Depsipeptides/pharmacology; Drug Liberation; Drug Therapy, Combination/methods; HIV-1/drug effects; Humans; Lymphocytes/cytology; Monocytes/cytology; Panobinostat/pharmacology; Particle Size; Polyelectrolytes; Surface Properties

Key words

Dendrimers; HIV-1 latency; Latency reversal agents; Nanomedicine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymers / Silanes / HIV Infections / Adjuvants, Immunologic / Anti-HIV Agents / Dendrimers Limits: Humans Language: En Journal: J Nanobiotechnology Year: 2019 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google